DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL‐18

Immunotherapies represented by programmed cell death protein 1/programmed cell death ligand 1 (PD‐1/PD‐L1) immune checkpoint inhibitors have made great progress in the field of anticancer treatment, but most colorectal cancer patients do not benefit from immunotherapy. Discoidin domain receptor 1 (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xiaofan, Xu, Xiaoxiao, Zhang, Yumei, Gao, Yuan, Zhou, Jiuli, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633303/
https://www.ncbi.nlm.nih.gov/pubmed/35969377
http://dx.doi.org/10.1111/cas.15533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633303/
https://www.ncbi.nlm.nih.gov/pubmed/35969377
http://dx.doi.org/10.1111/cas.15533

Ejemplares similares